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Abstract
Background: Most new cases of active tuberculosis in Norway are presently caused by imported strains and not
transmission within the country. Screening for tuberculosis with a Mantoux test of everybody and a chest X-ray of
those above 15 years of age is compulsory on arrival for asylum seekers.
We aimed to assess the effectiveness of entry screening of a cohort of asylum seekers. Cases detected by screen-
ing were compared with cases detected later. Further we have characterized cases with active tuberculosis.
Methods: All asylum seekers who arrived at the National Reception Centre between January 2005 - June 2006
with an abnormal chest X-ray or a Mantoux test ≥ 6 mm were included in the study and followed through the
health care system. They were matched with the National Tuberculosis Register by the end of May 2008.
Cases reported within two months after arrival were defined as being detected by screening.
Results: Of 4643 eligible asylum seekers, 2237 were included in the study. Altogether 2077 persons had a Mantoux ≥
6 mm and 314 had an abnormal chest X-ray. Of 28 cases with tuberculosis, 15 were detected by screening, and 13 at
4-27 months after arrival. Abnormal X-rays on arrival were more prevalent among those detected by screening.
Female gender and Somalian origin increased the risk for active TB.
Conclusion: In spite of an imperfect follow-up of screening results, a reasonable number of TB cases was identified
by the programme, with a predominance of pulmonary TB.
Background
In recent years most new tuberculosis (TB) cases in
Norway have occurred among immigrants from high
incidence countries. Rarely, new cases are due to trans-
mission within the country [1].
Low incidence countries have diverse policies on entry
screening of immigrants from high incidence countries.
These range from no screening at all, to pre-immigra-
tion screening or screening after arrival [2-4]. There is
an ongoing discussion about the content and effective-
ness of different screening programmes to control
tuberculosis [5,6]. Studies of screening of tuberculosis
among immigrants have given TB prevalences that
range from 0.1-1.2% [7-10], that can be due to differ-
ences in the characteristics of the populations and the
screening programmes.
Previous studies have shown differences between cases
detected by or outside the screening programme. Cases
found by screening had fewer symptoms and fewer posi-
tive cultures [11,12]. Other studies have shown that a
high number of TB cases have been detected in immi-
grant populations several years after immigration [5,6,13].
Risk factors for tuberculosis can be divided into the risk
for being infected and the risk for developing disease.
Typical risk factors for being infected are for instance
poverty and a history of being incarcerated. Country of
origin could be related both to risk for being infected and
for developing disease. Recent infection, reduced immu-
nity from other diseases like HIV or medical treatment,
intake of alcohol, smoking, and body weight loss are
related to the risk for developing disease [14-19].
The tuberculosis screening programme in Norway
Screening of all asylum seekers for tuberculosis is man-
datory on arrival in Norway. The aims of the screening
are to diagnose and treat active TB, and to diagnose
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observation for development of active TB in a three year
follow-up programme [20]. However, the programme
does not clearly differentiate between screening for
active and latent disease.
The National Reception Centre outside Oslo performs
a Mantoux test of everybody and a chest X-ray of persons
above the age of 15 years. According to the guidelines,
person who report symptoms suggestive of TB, or have
an abnormal chest X-ray, shall be referred to the Central
TB Clinic in Oslo for assessment of TB disease. Persons
with a Mantoux test ≥ 15 mm shall be referred to the
specialist health care for evaluation of TB disease or
infection by a chest physician or an internist. Everyone
with a Mantoux test result of 6-14 mm shall be followed
up by primary health care (PHC). Whenever definite risk
factors are identified, the patient shall be referred to a
specialist [21]. However, diagnosis of latent TB remains a
challenge and recommendations for diagnosis and
follow-up are ambiguous. TB disease is diagnosed on the
basis of symptoms, clinical examinations, chest X-ray and
positive bacteriology. In Norway, only specialists are
allowed to start TB treatment. Whenever a TB diagnosis
is confirmed and/or treatment for TB is started, a nom-
inal notification is sent to the National Tuberculosis Reg-
ister. After screening in the National Reception Centre,
asylum seekers move to other centres for asylum seekers
throughout the country or to private accommodations.
Surveillance data for TB in Norway, can not distin-
guish asylum seekers from immigrants. An earlier
Norwegian study on chest X-ray results from entry
screening of asylum seekers, concluded that an
improved follow-up of persons with an abnormal X-ray
is necessary [22]. Thus, they found that 11(14%) of the
cases that were not diagnosed by the arrival screening
but diagnosed later, had been inadequately followed up.
A previously published paper of the present cohort
showed that 194/314 (62%) subjects with an abnormal
X-ray had been seen by an internist, while altogether
758/2237 (34%) with a positive Mantoux test and/or an
abnormal X-ray had been followed up at the primary
health care level. Inadequate handling of screening
results was found at all levels of care [23].
The aims of the present study are to assess the effective-
ness of the tuberculosis entry screening programme for
diagnosing active TB in a cohort of asylum seekers and to
characterize all cases of active tuberculosis. Further we
aim to compare patients who were diagnosed by the
screening programme with those who were detected later.
Methods
Study population
All asylum seekers aged 18 years or over, and arriving at
the National Reception Centre from January 2005 - June
2006 were screened with a chest X-ray and a Mantoux
test. They were included in the study if they were avail-
able for follow-up and had an abnormal chest X-ray, a
Mantoux test ≥ 6 mm and/or a positive QuantiFERON®
TB Gold (QFT) test. Due to the study design it was not
possible to include children below 18 years of age in the
study. In case they needed specialist medical attention
or care, they were referred to paediatricians and not to
chest physicians.
Of 5112 asylum seekers screened during the study
period, 469 could not be followed up because they were
either deported, deceased or had no registered address,
leaving a total cohort of 4643 persons. Of the remaining
4643 (called the total cohort) 2293 had positive study
inclusion criteria. However, 56 were lost from the
National Reception Centre and hence, 2237 study parti-
cipants were included for follow-up [23].
An abnormal chest X-ray was defined as parenchymal
or pleural pathology, or calcifications. The X-rays were
interpreted by two independent readers and later
recoded for this study. A positive Mantoux test was
defined as ≥ 6 mm (PPD: RT 23, 2TU from SSI, Copen-
hagen, Denmark). An interferon-g release assay test:
(QuantiFERON® TB Gold in-tube test, Cellestis Ltd,
Carnegie, Victoria, Australia, QFT) was done as a sepa-
rate study on a subgroup of 912 participants [24].
Collection of study information
Subject demographics and screening results were col-
lected from the data files at the National Reception Cen-
tre. Further information was collected by one
registration form that was sent to the public health care
official in the municipality to where the asylum seeker
had moved. If any person in question had moved on,
the same form was sent to the appropriate municipality.
If the PHC form indicated that a referral had taken
place, a specialist form was sent to the appropriate
internist. A specialist form was also sent to the Central
TB Clinic when we received information from the
National Reception Centre that an asylum seeker had
either been referred there or had an abnormal X-ray.
Both forms collected recorded information about assess-
ment by health care personnel, plans for follow-up and
the reason for referral of the individual. In addition we
collected information about current addresses or reloca-
tions of study participants.
A match by name and date of birth for everyone in the
study population and the National Tuberculosis Register
was done in May 2008. The register holds information
about localisation of disease, culture results, the indivi-
dual physician who had reported the case, and some
background information about the specialist referral.
Cases reported to the National Tuberculosis Register
within two months after arrival were categorized as
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detected later.
Data registration and analyses
Study forms were scanned and entered into the SPSS
p r o g r a m( S P S Sf o rW i n d o w s ,v e r s i o n1 6 ,C h i c a g o ,I l l ,
USA). Comments and administrative information were
coded manually and entered to the same data file.
The study group and the TB cases were described by
proportions and 95% confidence intervals (CI). Time
from arrival to notification to the Tuberculosis Register
was approximated to the closest number of total
months.
The primary outcome diagnosed as active tuberculosis
or not, was analysed with logistic regression. The
assessed regressors were stratified age, gender, country
of origin (Somalian or not), marital status (married or
not), Mantoux (≥ 10 or not, and ≥ 15 or not) and X-ray
(abnormal or not). Variables in the univariate analysis
that changed the odds ratio (OR) of the other variables
with 0.2 or more were entered into the multivariable
analysis. The model was checked for correlations and
interactions.
Due to low number of cases, the secondary outcome;
i.e cases that were detected by screening or not, was stu-
died only by univariate logistic regression. Additional
regressors for the secondary outcome were a diagnosis
of pulmonary TB (as opposed to extra-pulmonary TB)
(yes/no) and a positive culture (yes/no).
Ethics
The Regional Committee for Medical Research Ethics
approved the study. The Norwegian Data Inspectorate,
Directorate for Health and Social Affairs, Ministry of
Labour and Social Inclusion, and the Research Commit-
tee at Ullevaal University Hospital all gave their
permission.
Results
There were 3222 (69%) males and 3333 (72%) were
between 18 to 34 years in the total cohort. The top five
countries of origin for asylum seekers were Iraq, Soma-
lia, Russia, Afghanistan and Serbia and Montenegro
with 2434 (52%) individuals [23].
Among the 2237 asylum seekers who fulfilled the
inclusion criteria and were included in the study group,
1563 (70%) were males and 1447 (65%) were 18-34
years of age (Table 1). An abnormal X-ray was found in
314 persons, 2077 had a Mantoux ≥ 6m ma n d2 7w e r e
included because of a positive QFT only. Compared to
those not included, the study group had significant
fewer persons in the lowest and more in the middle
and oldest age group, more were married, came from
Somalia, and had a BCG scar (data not shown).
Cases of tuberculosis
By end May 2008, 28 cases of tuberculosis were diag-
nosed. No case had recieved treatment for latent tuber-
culosis after arrival in Norway. The median time from
arrival until the National Tuberculosis Register was noti-
fied was two months (range 0-27). The diagnosis was
made within two and six months of arrival in 15 and 17
individuals, respectively. Eight patients were diagnosed
later than one year after arrival (Table 2).
Twenty two cases had M. tuberculosis and one case
had M. Africanum confirmed by culture. Of the remain-
d e r ,o n ew a sc u l t u r en e g a t i v ea n df o u rh a du n k n o w n
bacteriology. There were 18 individuals with pulmonary
and eight with extra-pulmonary TB, while the localiza-
tion was unknown in two individuals. Somalian origin
was associated with extra-pulmonary TB (data not
s h o w n ) .O f1 5w o m e nw i t ht u b e r c u l o s i s ,1 2w e r ef r o m
Somalia. The Somalian females median age was 25 years
(range 21-49). Mantoux ≥ 15 mm on arrival was found
in 12 (43%) cases and Mantoux ≥ 10 mm in 20 (69%)
cases (Table 2). Lack of a BCG vaccination scar was not
associated with active TB (data not shown).
In a univariate analysis for all cases of active TB, a posi-
tive association was found with a positive chest X-ray,
Mantoux ≥ 15 mm, Mantoux ≥ 10 mm, female gender,
and Somalian origin (Table 3). In adjusted logistic regres-
sion models, gender and country of origin were entered
into the model. A positive association with active TB was
found for female gender and Somalian origin when either
Mantoux ≥ 10 mm, or Mantoux ≥ 15 mm, or a positive
chest X-ray were included (Table 4). However, in the
adjusted model neither Mantoux ≥ 10 mm nor Mantoux
≥ 15 mm was associated with active TB.
The yield of screening
Fifteen cases were detected within two months after
arrival. Twelve of the cases had positive X-ray findings
w h e nt h e ya r r i v e da n d1 3h a ds y m p t o m so fT Ba tt h e
time of diagnosis. There were twelve cases of pulmonary
and two with extra-pulmonary TB and one with
unknown localization. Thirteen had a positive culture
(Table 2 and 5).
All cases diagnosed by screening were reported from
hospitals in the Oslo area. Of the 12 cases with an
abnormal X-ray on arrival, six had visited the Central
TB Clinic where all should have been referred according
to the guidelines.
Of the 13 cases that were not detected through the
screening programme, two cases were diagnosed from
three to six months after arrival, (four and five months
respectively), one with pulmonary and one with extra-
pulmonary TB. One of the cases was confirmed by cul-
ture. None of them had been examined at the Central
TB Clinic. Still, one had reported symptoms on arrival.
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to 27 months after arrival. Five of them had pulmonary
and five other extra-pulmonary TB. In the last case the
localisation was unknown. Nine of these 11 patients had
the diagnosis confirmed by culture. Moreover, three
patients had an abnormal X-ray on the arrival screening
and 12 patients had a Mantoux ≥ 10 mm (Table 2).
All three cases who had an abnormal X-ray on arrival
and were detected later than six months after arrival,
had been examined at the Central TB Clinic just after
arrival, but were judged not to have TB disease at that
time. They were advised to have additional follow-up if
there was a future doubt about the diagnosis. Thus, they
most likely developed the disease later. Ten of the 11
late cases were diagnosed at different hospitals around
the country. They had all been referred from PHC due
to clinical symptoms. One case diagnosed after ten
months had been referred from PHC to specialist for
assessment of screening results following a move to an
asylum seekers centre in the community.
In univariate logistic regression of cases detected by
screening or not, for an abnormal X-ray the OR was 9.0
(1.6-50.7). The distinction between pulmonary TB and
extra-pulmonary TB detected by screening gave an OR of
6.0 (0.9-39.2). However, the latter OR was not significant
(table 5). We found no other associations between time of
diagnosis and either demographics or screening results.
Discussion
The yield of the Norwegian TB screening programme
that was aimed at a high risk population and defined as
cases detected within 2 months of arrival was 15/2237
(0.7%) cases. Our results are comparable to that of other
similar studies where the prevalences ranged from
0.1.-1.2% [7-10].
Two cases were diagnosed between three and six
months after arrival and were probably missed by the
screening. The other 11 cases were not diagnosed as a
part of the screening programme. Cases identified by
screening more often had abnormal X-rays on arrival.
Female gender and Somalian origin increased the risk
for TB disease.
A major objective of the screening programme is to
diagnose pulmonary TB as early as possible to minimize
risk of transmission to others within the country. This
seemed to have been the case since 12 of the 15 cases
detected had pulmonary TB. Through the match with
the Tuberculosis Register we detected several cases diag-
nosed at different hospitals in the Oslo area. However,
we could not trace any information about referrals for
these patients through the files at the National Recep-
tion Centre or the study forms. Previously we have
reported that 62% of persons with an abnormal X-ray
on screening and 70% of those with parenchymal find-
ings had been seen by a specialist [23]. Thus, we have
reasons to believe that more cases had been referred to
specialist than we were able to identify through our
study.
A pertinent question is whether cases that were
detected later than two months after arrival could have
been detected earlier or prevented. One individual who
was diagnosed four months after arrival had been ill
since arrival. A second individual diagnosed five months
after arrival, was found through contact tracing and had
Table 1 Numbers, percents and CI by demographics and screening results for study group and TB cases
Groups Study group N = 2237 TB cases N = 28
Numbers (%) 95% CI Numbers (%) 95% CI
Age groups 18-34 years 1447 (65) 63-67 22 (79) 63-94
35-49 years 656 (29) 27-31 4 (14) 1-27
>50 years 134 (6) 5-7 2 (7) -2-17
Gender Males 1563 (70) 68-72 13 (46) 28-65
Females 674 (30) 28-32 15 (54) 35-72
Marital status Married 1034 (46) 44-48 10 (36) 18-53
Not married 1203 (54) 52-56 18 (64) 47-82
The five most frequent countries Iraq 224 (10) 9-11 1 (3.6) -3-10
Somalia 457 (20) 19-22 15 (54) 35-72
Russia 182 (8) 7-9 4 (14) 1-27
Afghanistan 166 (7.4) 6-9 1 (3.6) -3-10
Serbia and Montenegro 149 (6.7) 6-8 2 (7.1) -2-17
Mantoux test <6 mm 146 (6.5) 6-8 1 (3.6) -3-10
6-9 mm 680 (30) 28-32 2 (7.1) -2-17
10-14 mm 760 (34) 32-36 8 (29) 12-45
≥ 15 mm 637 (28) 27-30 12 (43) 25-61
Abnormal X-ray 314 (14) 13-15 16 (57) 39-75
Harstad et al. BMC Public Health 2010, 10:670
http://www.biomedcentral.com/1471-2458/10/670
Page 4 of 8symptoms at the time of referral. However, we do not
k n o wt h et i m ef r o ms y m p t o m st od i a g n o s i sf o rt h e
remaining individuals. All 11 patients who were detected
later than six months after arrival had either abnormal
X-rays or a positive Mantoux test at entry. According to
the guidelines they should have been referred to a spe-
cialist or examined in PHC. Seven of them should have
been, but were not referred to specialist to reach a firm
conclusion about entry findings. We believe that some
of these cases could have been detected with active TB
earlier or been given treatment for latent tuberculosis.
On the other hand, the Norwegian guidelines give no
definite recommendations fort r e a t m e n tf o rl a t e n tT B .
Previously we have published that as few as 30/2237
(1.3%) individuals of the same cohort were treated for
latent tuberculosis [25].
Asylum seekers were not interviewed about symptoms
on arrival, and registration of symptoms seems to be
incidental. Possibly, a medical interview could have
raised suspicion in some of the cases, particularly the
ones with extra-pulmonary TB. On the other hand,
screening for TB in a Brazilian prison showed that 1/3
of the TB cases denied any symptoms during an initial
interview, and several patients with a cough of more
than three weeks duration considered that they had a
“normal” cough [26].
As more cases found through screening in our study
had abnormal X-rays and tended to have more pulmon-
ary TB, an abnormal X-ray was the main indication for
an immediate follow-up. There were no differences in
the proportion with positive cultures between the
groups diagnosed inside or outside the screening pro-
gramme. This could have been a spurious finding and
due to low numbers. Others have reported that cases
detected outside the screening programme showed an
increase in the number of positive cultures [11].
Table 2 TB cases diagnosed by screening or not by demographics, screening results and TB Register report
Case
number
Diagnosed
by
screening
Arrival to
diagn.
(months)
Age on
arrival
(years)
Gender Married Country of
origin
Mantoux
result on
arrival (mm)
X-ray
findings on
arrival
Culture
results on
diagnosis
Localisation
of disease
1 Yes 0 25 F Yes Somalia 9 Parenchymal Positive Pulmonary
2 Yes 0 28 F Yes Somalia No Parenchymal Positive Pulmonary
3 Yes 0 24 M No Afghanistan 12 Parenchymal Positive Pulmonary
4
a Yes 0 24 F No Somalia 2 Normal No Pulmonary
5 Yes 0 43 M Yes Russia 18 Parenchymal Positive Pulmonary
6 Yes 0 30 F No Somalia 16 Parenchymal Positive Lymphatic
7 Yes 0 25 M No Somalia No Parenchymal Positive Pulmonary
8 Yes 0 31 M No Serbia/
Montenegro
No Parenchymal Positive Pulmonary
9 Yes 1 49 F No Somalia 17 Parenchymal Positive Pulmonary
10 Yes 1 23 M No China 15 Parenchymal Positive Pulmonary
11 Yes 1 22 M No Serbia/
Montenegro
No Pleura Positive Pulmonary
12 Yes 1 24 F No Somalia 10 Normal Positive Unknown
13 Yes 2 50 M Yes Iraq No Parenchymal Negative Pulmonary
14 Yes 2 33 M No Algeria 10 Parenchymal Positive Pulmonary
15 Yes 2 29 F Yes Congo rep 20 Normal Positive GI/periton.
16 No 4 19 M No Somalia 15 Normal Positive Lymphatic
17 No 5 51 F No Yemen 15 Pleural No Pulmonary
18 No 8 26 M No Russia 8 Parenchymal Positive Pulmonary
19 No 10 37 M Yes Russia 20 Normal No Pulmonary
20 No 11 21 F Yes Somalia 11 Normal Positive Lymphatic
21 No 15 26 F No Syria 19 Normal Positive Pulmonary
22 No 15 26 F No Somalia 13 Normal Positive CNS
23 No 15 23 F Yes Somalia 13 Normal Positive Pulmonary
24 No 16 45 F No Somalia 17 Normal No Unknown
25 No 17 25 F No Somalia 20 Parenchymal Positive Lymphatic
26 No 20 31 M Yes Russia 14 Normal Positive Pulmonary
27 No 20 25 M Yes Somalia 15 Parenchymal Positive GI/periton.
28 No 27 24 F No Somalia 14 Normal Positive Lymphatic
aThis case was included because of a positive QFT test
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arrival screening there is an increased risk for active TB
for several years after arrival. However, all these late
cases have been interpreted as incident ones [5,6,27].
This is particularly the case for extra-pulmonary TB [6].
The association of an increased risk for active TB in
asylum seekers of Somalian origin is in accordance with
the findings of several other studies [5,22,28,29]. Simi-
larly, the association between Somalian origin and extra-
pulmonary TB, has also been shown in a previous Nor-
wegian study [30].
In our study females had a significant increased risk
for active TB. Further, 12 of the 15 females with tuber-
c u l o s i sw e r ef r o mS o m a l i a .W eh a v en oi n f o r m a t i o n
whether females from Somalia arriving in Norway have
other risk factors. Low numbers in the present study or
other health seeking behaviours in their home country
may explain why our results differ from other studies
from developing countries where males have higher risk
[31]. However, studies from Western countries at the
time when TB was more prevalent, showed an increased
risk for females of fertile age [31].
We have analysed data from the arrival screening of a
complete cohort of asylum seekers and matched subjects
with positive screening information with data from the
National Tuberculosis Register. However, we did not
match those without positive screening results as they
are not supposed to be followed up. Moreover, we have
no data on the several study subjects who had left Nor-
way during the study period. This may have influenced
the number of people who were available for analysis
and made exact estimating of incidences impossible.
Children below 18 were not included in the study and
our conclusions can not be applied to them.
Asylum seekers frequently change their name and/or
date of birth which may have given an artificial reduc-
tion in the matching procedure with the National
Tuberculosis Register. Such changes of demographic
data may have resulted in underreporting and incom-
plete responses on our study forms.
Smear results were inavailable for analysis because of
the limited numbers that were reported to the National
Tuberculosis Register.
Only persons with an abnormal X-ray or where data
stated that they had been referred from the National
Reception Centre to a specialist, were matched with the
Central TB Clinic. This procedure could have led to
some underreporting of cases seen by specialist because
a similar match was not done with other hospitals.
We defined patients who were diagnosed within two
months after arrival as detected by the screening pro-
gramme. Hence, misclassification of the cases may have
led to over - as well as underestimation of the yield of
the programme. In most cases, the files at the Tubercu-
losis Register gave no clear answer whether the clinical
examination was the result of screening or not. Nor did
they report the length of time between symptom onset
and the TB diagnosis. Possibly, some late cases may
have been reinfected after arrival to Norway, but infec-
tion rate within the country is generally quite low [1].
Conclusions
More patients were referred to specialist and more cases
found than we were able to detect from the follow-up
study. Still, in spite of an imperfect follow-up of
Table 3 Univariate analysis of associations between
demographics, screening results and active tuberculosis
Univariate analysis
Cases
N=2 8
Non-cases
N = 2209
OR 95%CI
Age 18-34 22 1425 1(ref)
Age 35-49 4 652 0.42 0.14-1.2
Age ≥ 50 2 132 1.6 0.5-5.3
Male 13 1550 1(ref)
Female 15 659 2.7 1.3-5.7
Unmarried 18 1016 1(ref)
Married 10 1193 0.64 0.30-1.4
Not from Somalia 13 1767 1(ref)
Somalia 15 442 4.6 2.2-9.8
Mantoux
6-9 mm
2 678 0.17 0.04-0.73
Mantoux
≥ 10 mm
20 1377 4.0 1.2-13.4
Mantoux
≥ 15 mm
12 625 2.8 1.2-6.3
Abnormal
X-ray
16 298 8,6 4.0-18.3
Table 4 Multivariable analysis of associations between
demographics, screening results and active tuberculosis
Mantoux ≥ 10
mm
Mantoux ≥ 15
mm
Abnormal X-
rays
Variables OR 95%
CI
OR 95%
CI
OR 95%
CI
Male 1(ref) 1(ref) 1(ref)
Female 2.9 1.2-6.8 2.8 1.2-6.6 2.6 1.2-5.7
Not from
Somalia
1(ref) 1(ref) 1(ref)
Somalia 4.0 1.7-9.4 4.2 1.8-9.8 4.7 2.2-
10.1
Mantoux ≥ 10
mm
2.9 0.8-9.9 ——— ——— ——— ———
Mantoux
≥ 15 mm
——— ——— 1.9 0.8-4.4 ——— ———
Abnormal X-ray ——— ——— ——— ——— 9.7 4.5-
21.2
Three multivariable models where included variables are Somalia, gender, and
either Mantoux ≥ 10 mm, Mantoux ≥ 15 mm or an abnormal X-ray
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through screening, most of whom had pulmonary TB.
As a consequence of this study, we will underscore that
an immediate follow-up of everyone who has an abnor-
mal X-ray should be verified by a quality assurance sys-
tem. In cases of latent TB, treatment should always be
considered. Special measures for all asylum seekers from
Somalia should also be considered.
Further studies are needed to assess cost-effectiveness
of the screening programme.
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